GlaxoSmithKline PLC | Balance Sheet
Fiscal year is January-December. All values GBP Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,755
4,553
6,030
5,142
3,979
3,958
Total Accounts Receivable
5,281
4,486
5,488
5,917
5,950
6,322
Inventories
3,900
4,231
4,716
5,102
5,557
5,476
Other Current Assets
291
1,408
353
550
421
1,171
Total Current Assets
15,227
14,678
16,587
16,711
15,907
16,927
Net Property, Plant & Equipment
8,872
9,052
9,668
10,808
10,860
11,058
Total Investments and Advances
1,526
1,454
1,462
1,248
1,109
1,627
Long-Term Note Receivable
559
642
732
886
227
141
Intangible Assets
13,488
12,044
21,834
24,741
23,296
22,991
Other Assets
330
93
258
313
1,186
1,435
Total Assets
42,086
40,651
53,446
59,081
56,381
58,066
ST Debt & Current Portion LT Debt
2,789
2,943
1,308
4,129
2,825
Accounts Payable
2,739
2,790
3,120
3,596
3,528
Income Tax Payable
1,452
945
1,421
1,305
995
Other Current Liabilities
6,697
6,617
7,568
9,971
19,221
Total Current Liabilities
13,677
13,295
13,417
19,001
26,569
Long-Term Debt
15,456
15,841
15,324
14,661
14,264
Provision for Risks & Charges
2,741
3,724
3,649
4,742
4,175
Deferred Taxes
1,391
2,243
1,383
2,440
2,400
Other Liabilities
1,707
2,410
10,656
13,780
6,488
Total Liabilities
34,274
35,715
44,568
54,118
52,892
Common Equity (Total)
6,997
4,263
5,114
1,124
68
Total Shareholders' Equity
6,997
4,263
5,114
1,124
68
Total Equity
7,812
4,936
8,878
4,963
3,489
Liabilities & Shareholders' Equity
42,086
40,651
53,446
59,081
56,381
Accumulated Minority Interest
815
673
3,764
3,839
3,557
About GlaxoSmithKline
View Profile
